...
首页> 外文期刊>BioMed research international >Molecular Characterization andIn SilicoAnalysis of Naturally Occurring TEM Beta-Lactamase Variants among PathogenicEnterobacteriaceaeInfecting Indian Patients
【24h】

Molecular Characterization andIn SilicoAnalysis of Naturally Occurring TEM Beta-Lactamase Variants among PathogenicEnterobacteriaceaeInfecting Indian Patients

机译:感染印度患者的致病性肠杆菌科自然存在的TEMβ-内酰胺酶变异体的分子表征和计算机分析

获取原文

摘要

Cephalosporin resistance, particularly due toblaTEMencodedβ-lactamases, amongEnterobacteriaceaeis, though, an increasing public health problem in India; their circulating genetic variants remain unknown. The present study deals with determination ofblaTEMvariants among 134 pathogenicEnterobacteriaceaeof Indian origin. Their resistance profile against 3rd generation cephalosporins was determined. The presence ofblaTEMvariants among the bacterial plasmids was characterized by PCR followed by sequencing. Intergenic relations among the variants was determined by phylogenetic analysis.blaTEMprotein were modeled by Modeller9v5 and verified. The catalytic pockets were characterized, and their interaction with cephalosporins was analyzed using AutoDock tools. More than 87% of isolates showed cephalosporin resistance with ESBL production among 57.8% ofEscherichia coliand 50.6% ofklebsiella pneumoniae.blaTEM-1(84.21%),blaTEM-1like (3.94%),blaTEM-33(3.94%),blaTEM-116(3.94%),blaTEM-169(3.94%), andblaTEM-190(7.89%) were detected in 76 isolates. Four variants, namely,blaTEM-1like,blaTEM-33,blaTEM-169, andblaTEM-190, coexisted in 3 isolates. The largest catalytic pocket ofblaTEM-33explained its expanded activity towardsβ-lactam-β-lactamase inhibitor combinations. Molecular docking indicated differential resistance pattern ofblaTEMvariants.
机译:肠杆菌科细菌对头孢菌素的耐药性,特别是由于blaTEM编码的β-内酰胺酶引起的耐药性在印度日益严重。其循环遗传变异仍然未知。本研究涉及确定印度起源的134种致病性肠杆菌科细菌中blaTEM变异。确定了它们对第三代头孢菌素的抗药性。通过PCR然后测序来表征细菌质粒中blaTEM变体的存在。通过系统进化分析确定变体之间的基因间关系。通过Modeller9v5对blaTEM蛋白进行建模并验证。表征了催化口袋,并使用AutoDock工具分析了它们与头孢菌素的相互作用。在57.8%的大肠杆菌和50.6%的肺炎克雷伯菌中,超过87%的分离株表现出对ESBL产生的头孢菌素耐药性。blaTEM-1(84.21%),blaTEM-1like(3.94%),blaTEM-33(3.94%),blaTEM-116(在76株菌株中检出了3.94%),blaTEM-169(3.94%)和blaTEM-190(7.89%)。 blaTE-1like,blaTEM-33,blaTEM-169和blaTEM-190四个变异体共存在3个分离株中。 blaTEM-33的最大催化口袋解释了其对β-内酰胺-β-内酰胺酶抑制剂组合的扩展活性。分子对接表明blaTEM变体的差异抗性模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号